Skip to main content

Upcoming holiday closures 

Quest Patient Service Centers will be closed on Friday, July 3 and Saturday, July 4, 2026, in observance of Independence Day, and to give our frontline team the time to recharge. Don't let the holiday interrupt your care. Plan your visit today.

Hide
Quest Diagnostics

Xylazine Detection in Clinical Urine Specimens Ordered for Comprehensive Drug Screening

ADLM 2025

Association for Diagnostics and Laboratory medicine

Chicago, IL, July 27-31 , 2025

Poster presentation: Xylazine Detection in Clinical Urine Specimens Ordered for Comprehensive Drug Screening

Authors: Chen L and Jenkins AJ

Medical Specialty: Prescription drug monitoring, Toxicology

Related content

Test FAQ
Novel Psychoactive Substances (NPS) Panel
Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing
Audio Podcast
Novel Psychoactive Substances (NPS): A Dangerous, Widespread Public Health Issue
On-Demand Webinar
The Growing Crisis of Novel Psychoactive Substances
Audio Podcast
Patients with Substance Use Disorders in Medication-assisted Treatment (MAT)
Test FAQ
Pain Management Antipsychotics With Confirmation Serum and Urine

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.